Schizophrenia
Conditions
Brief summary
The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.
Interventions
DRUGquetiapine fumarate vs risperidone
Sponsors
AstraZeneca
Study design
Primary purpose
TREATMENT
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Male / Female, 18-65 years old * Schizophrenia (as per DSM IV)
Exclusion criteria
* Concurrent use of psychotropic medication * Does not fulfill moderately ill on CGI
Countries
United States
Outcome results
None listed